Renaissance Technologies’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3M Buy
368,100
+164,100
+80% +$1.34M ﹤0.01% 1845
2025
Q1
$1.6M Buy
204,000
+185,500
+1,003% +$1.46M ﹤0.01% 2138
2024
Q4
$275K Sell
18,500
-165,400
-90% -$2.46M ﹤0.01% 3072
2024
Q3
$2.81M Buy
183,900
+101,500
+123% +$1.55M ﹤0.01% 1800
2024
Q2
$1.25M Sell
82,400
-158,100
-66% -$2.41M ﹤0.01% 2195
2024
Q1
$4.54M Buy
240,500
+117,000
+95% +$2.21M 0.01% 1477
2023
Q4
$2.36M Sell
123,500
-19,300
-14% -$369K ﹤0.01% 1855
2023
Q3
$2.56M Buy
+142,800
New +$2.56M ﹤0.01% 1709
2021
Q3
Sell
-275,700
Closed -$7.57M 3776
2021
Q2
$7.57M Buy
275,700
+18,800
+7% +$516K 0.01% 1372
2021
Q1
$7.21M Buy
+256,900
New +$7.21M 0.01% 1415
2020
Q2
Sell
-261,416
Closed -$3.63M 3708
2020
Q1
$3.63M Buy
261,416
+44,178
+20% +$613K ﹤0.01% 1751
2019
Q4
$2.19M Buy
217,238
+76,400
+54% +$772K ﹤0.01% 2285
2019
Q3
$1.28M Buy
140,838
+106,238
+307% +$967K ﹤0.01% 2493
2019
Q2
$275K Buy
+34,600
New +$275K ﹤0.01% 3202